ALPS Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

ALPS Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.41M	Sell	111,895 -28,330	-20%	-$611K	0.01%	338
2025 Q1	$2.33M	Buy	140,225 +5,681	+4%	+$94.4K	0.01%	330
2024 Q4	$2.47M	Buy	134,544 +7,448	+6%	+$137K	0.02%	316
2024 Q3	$1.95M	Sell	127,096 -1,770	-1%	-$27.2K	0.01%	364
2024 Q2	$2.09M	Buy	128,866 +12,644	+11%	+$205K	0.01%	329
2024 Q1	$2.15M	Buy	116,222 +4,489	+4%	+$83K	0.02%	337
2023 Q4	$3.5M	Sell	111,733 -9,077	-8%	-$284K	0.03%	260
2023 Q3	$2.52M	Buy	120,810 +1,274	+1%	+$26.6K	0.02%	290
2023 Q2	$2.86M	Buy	119,536 +12,653	+12%	+$303K	0.02%	254
2023 Q1	$2.01M	Sell	106,883 -2,821	-3%	-$53.1K	0.02%	289
2022 Q4	$1.75M	Buy	109,704 +21,338	+24%	+$340K	0.02%	322
2022 Q3	$1.45M	Sell	88,366 -6,118	-6%	-$100K	0.01%	367
2022 Q2	$1.33M	Sell	94,484 -71,197	-43%	-$1M	0.01%	401
2022 Q1	$4.01M	Sell	165,681 -20,363	-11%	-$493K	0.04%	142
2021 Q4	$4.34M	Sell	186,044 -10,850	-6%	-$253K	0.05%	159
2021 Q3	$3.27M	Sell	196,894 -13,285	-6%	-$221K	0.03%	206
2021 Q2	$5.13M	Buy	+210,179	New	+$5.13M	0.05%	175
2019 Q4	–	Sell	-211,163	Closed	-$7.6M	–	814
2019 Q3	$7.6M	Sell	211,163 -89,587	-30%	-$3.22M	0.06%	122
2019 Q2	$8.04M	Buy	+300,750	New	+$8.04M	0.06%	126
2017 Q4	–	Sell	-120,544	Closed	-$4.54M	–	841
2017 Q3	$4.54M	Buy	120,544 +10,381	+9%	+$391K	0.03%	144
2017 Q2	$3.07M	Buy	110,163 +5,968	+6%	+$166K	0.02%	161
2017 Q1	$3.58M	Sell	104,195 -12,196	-10%	-$419K	0.02%	153
2016 Q4	$3.36M	Sell	116,391 -36,267	-24%	-$1.05M	0.02%	148
2016 Q3	$4.86M	Buy	+152,658	New	+$4.86M	0.04%	140
2016 Q1	–	Sell	-132,936	Closed	-$4.74M	–	622
2015 Q4	$4.74M	Sell	132,936 -24,709	-16%	-$881K	0.05%	123
2015 Q3	$52.1K	Buy	157,645 +58,112	+58%	+$19.2K	0.05%	111
2015 Q2	$4.17M	Buy	99,533 +49,968	+101%	+$2.09M	0.04%	128
2015 Q1	$1.62M	Buy	+49,565	New	+$1.62M	0.01%	160